Feb. 27 court date for Charter test of stem cell program; Foes say enterprise is illegal because it's outside state control
By San Francisco Chronicle,
San Francisco Chronicle
| 12. 07. 2005
Alameda County Superior Court Judge Bonnie Sabraw set a trial for Feb. 27 to decide whether California's Proposition 71 stem cell program violates the state Constitution.
Sabraw presided over a 30-minute hearing in her Hayward courtroom Tuesday to work out a timetable for the next critical phase in litigation brought by plaintiffs who say the voter-approved stem cell enterprise is illegal because it operates outside "the exclusive management and control of the state."
While the court proceeding was under way, stem cell policymakers were in Southern California to lay groundwork for their long-awaited first round of financing. Their goal is to generate up to $50 million, more than enough to cover initial training grants for would-be stem cell scientists at California medical schools and other nonprofit research institutions.
Officials meeting at City of Hope Cancer Research Center outside Los Angeles adopted guidelines governing profit rights and other "intellectual property" rules for researchers receiving Prop. 71 grants. A much more detailed review of final policies is just beginning.
Critics argue that stem cell policy makers are allowing researchers too much control...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...